The enzyme RT of HIV-1 is responsible for copying the viral singlestranded RNA genome to double-stranded DNA (dsDNA) in the cytoplasm of infected cells. This 117-kDa heterodimeric (p66 and p51) protein performs three catalytic steps: (i) RNA-dependent DNA polymerization to synthesize a (−) strand DNA complementing the viral (+) strand RNA genome, (ii) RNase H cleavage of the RNA strand, and (iii) DNA-dependent DNA polymerization to synthesize dsDNA using the (−) strand DNA as the template. The dsDNA is transported into the nucleus as a preintegration complex and integrated into the chromosome of the infected cell. HIV-1 infection is chronic and requires lifelong treatment. Emergence of drug-resistant HIV-1 strains and side effects impede the long-term use of drugs; therefore, new drugs against existing and new targets are required and are constantly being developed. HIV-1 infection, in general, is treated with combinations of three or more antiviral agents. Twenty-six individual drugs are approved, thirteen of which inhibit RT (http://www.fda.gov/ForConsumers/ byAudience/ForPatientAdvocates/HIVandAIDSActivities/ ucm118915.htm). RT drugs are either (i) nucleoside or nucleotide inhibitors (NRTIs) that are incorporated into the growing DNA strand and act as chain terminators, because NRTIs lack a 3′-OH group, or (ii) NNRTIs (also referred to below as non-nucleosides) that are allosteric inhibitors of DNA polymerization. Several anti-retroviral therapy regimens use non-nucleosides in combination with NRTIs; nevirapine, delavirdine, efavirenz, etravirine and rilpivirine (also known as TMC278 or Edurant) are non-nucleoside drugs.
a r t i c l e s
The enzyme RT of HIV-1 is responsible for copying the viral singlestranded RNA genome to double-stranded DNA (dsDNA) in the cytoplasm of infected cells. This 117-kDa heterodimeric (p66 and p51) protein performs three catalytic steps: (i) RNA-dependent DNA polymerization to synthesize a (−) strand DNA complementing the viral (+) strand RNA genome, (ii) RNase H cleavage of the RNA strand, and (iii) DNA-dependent DNA polymerization to synthesize dsDNA using the (−) strand DNA as the template. The dsDNA is transported into the nucleus as a preintegration complex and integrated into the chromosome of the infected cell. HIV-1 infection is chronic and requires lifelong treatment. Emergence of drug-resistant HIV-1 strains and side effects impede the long-term use of drugs; therefore, new drugs against existing and new targets are required and are constantly being developed. HIV-1 infection, in general, is treated with combinations of three or more antiviral agents. Twenty-six individual drugs are approved, thirteen of which inhibit RT (http://www.fda.gov/ForConsumers/ byAudience/ForPatientAdvocates/HIVandAIDSActivities/ ucm118915.htm). RT drugs are either (i) nucleoside or nucleotide inhibitors (NRTIs) that are incorporated into the growing DNA strand and act as chain terminators, because NRTIs lack a 3′-OH group, or (ii) NNRTIs (also referred to below as non-nucleosides) that are allosteric inhibitors of DNA polymerization. Several anti-retroviral therapy regimens use non-nucleosides in combination with NRTIs; nevirapine, delavirdine, efavirenz, etravirine and rilpivirine (also known as TMC278 or Edurant) are non-nucleoside drugs.
Structures of RT have been known since almost two decades ago, when binary complexes of RT with nevirapine 1 and with DNA 2 were reported. An innovative protein-nucleic acid cross-linking technique helped obtain an RT-DNA-dTTP ternary complex structure 3 . Subsequently, a large number of RT structures have been studied that help in understanding the enzymatic activities, inhibition and mechanisms of drug resistance 4, 5 , and these studies have aided the design of new drugs 6 . RT has a hand-like structure 7 (Fig. 1) . The palm contains the polymerase active site and the non-nucleoside-binding pocket, which are separated by ~10 Å. The major conformational changes in RT 8 characterized by structural studies are (i) the thumb lifts up to bind nucleic acid 9, 10 , (ii) the fingers fold down to capture dNTP substrates in the presence of nucleic acid 3 , and (iii) non-nucleoside binding leads to thumb hyperextension. Pre-steady-state and steady-state kinetics data suggest that the binding of a non-nucleoside inhibits the chemical step of DNA polymerization 11, 12 ; however, the precise effects of this binding on nucleic acid and dNTP are unclear 13 , and RT-nonnucleoside association and dissociation are complex processes 14 that are not yet conclusively explained by kinetics experiments. Binding of a non-nucleoside can enhance p66 and p51 dimerization 15 . Recent single-molecule FRET studies 16, 17 revealed that RT frequently flips and slides over nucleic acid substrates in the process of copying the viral RNA into dsDNA. An RT-nucleic acid complex is stabilized in a polymerization-competent conformation when dNTP is present. By contrast, nevirapine has a destabilizing effect that has been interpreted as the consequence of loss of thumb and fingers interactions with nucleic acid 17 . Binding of an incoming dNTP at the polymerase active site decreased the efficiency of cross-linking, whereas NNRTI binding increased cross-linking 18 ; site-directed photo-cross-linking of the fingers subdomain of HIV-1 RT to an extended template was carried out using photolinkers of different length to monitor changes in the distance between particular positions on the surface of the protein and a nucleic acid substrate. Pre-steady state kinetics analyses 11, 12, 19 reported no decrease in binding of DNA or dNTP upon binding of an NNRTI; in fact, dNTP-binding was enhanced at saturating concentrations.
The postulated mechanisms of inhibition by non-nucleosides include (i) restriction of thumb mobility 1 , (ii) distortion of the catalytic triad 20 , (iii) repositioning of the primer grip 21 , and (iv) loosening of the thumb and fingers clamp 17 .
Non-nucleosides indirectly interfere with DNA polymerization. Therefore, structures of RT-nucleic acid-NNRTI (±dNTP or analog) complexes are essential for understanding inhibition of polymerization and excision 22, 23 by a non-nucleoside and to visualize how both types of RT drugs synergistically inhibit DNA polymerization 24 . Here we report an RT-DNA binary crystal form in which RT-DNA could undergo conformational changes to accommodate 3′-azido-3′-deoxythymidine 25 (known as AZT or zidovudine) triphosphate (AZTTP) at the dNTP-binding site, or nevirapine at the non-nucleoside-binding pocket. The differences between the structures directly reflect the impact of nevirapine binding on the RT-DNA complex and help illustrate the structural basis of nonnucleoside inhibition.
RESULTS

Polymerase competent state of RT-DNA binary complex
In completing synthesis of a dsDNA from the viral RNA genome, RT makes several jumps and binds different nucleic acid sequences 26 . Recent single-molecule studies 16, 17 revealed that RT binds a nucleic acid in two distinct modes: a polymerase-competent mode (mode-1), analogous to that observed in crystal structures, and a switched mode (mode-2). Binding of dNTP stabilizes mode-1 for RT-nucleic acid complexes, and only the mode-1 complex can bind dNTP and incorporate nucleotide. Previous structures of RT in complex with non-cross-linked nucleic acids 2, 27 were naturally formed by mixing dsDNA or RNA-DNA with RT in solution; however, RT cross-linking to DNA 3 stabilized the complex for studying the polymerase-relevant states of the enzyme. In our current study, RT-DNA cross-linking was used to obtain a stable polymerase-relevant high-resolution structure in the presence of a non-nucleoside drug, which pertains to the fact that nevirapine binding increases the dynamics of an RT-nucleic acid complex, as revealed by the single-molecule FRET study 17 .
AZTTP or nevirapine binding to RT-DNA complex in a crystal
Recent successful experiments were designed on the basis of the following facts: (i) a typical protein crystal has >50% disordered solvent, which may permit repositioning of a flexible domain if the domain is not constrained by interactions with neighboring symmetry-related molecules in the crystal; (ii) in an earlier experiment, we used soaking to replace tenofovir diphosphate with its natural counterpart dATP in a crystal 28 ; and (iii) dNTP analogs have been successfully soaked into RT-DNA crystals 29 . Therefore, a crystal form of the RT-DNA complex in which the thumb and fingers subdomains have enough room to flex may permit binding of dNTPs and non-nucleosides by soaking. We discovered such a crystal form for the D498N mutant RT cross-linked with DNA containing an AZT-terminated primer (see Online Methods), and we soaked nevirapine and AZTTP as the incoming dTTP analog (Fig. 1 ). An attempt to crystallize RT cross-linked with a 2′,3′-dideoxythymidine (ddT) primer-terminated DNA did not produce diffraction quality crystals; change in DNA sequence and incoming dNTP in the past had led to new crystal forms 30 or were unsuccessful in yielding crystals. Our attempts enabled us to obtain the crystal structures of RT-DNA, RT-DNA-AZTTP Figure 1 Polymerase domain of HIV-1 RT in complex with DNA. Nevirapine and AZTTP are placed based on the superposition of the palm subdomain of nevirapine-and AZTTP-ternary structures, respectively, on the RT-DNA structure. The 3′-azido group of the AZT-terminated primer in the current RT-DNA and AZTTP-ternary structures occupies the metal A position, whereas metal B is present in the AZTTP-ternary structure; metal ion A is positioned based on its location in the dTTP-ternary structure 3 . RT binds dNTP and catalytically incorporates nucleotides by a cationdependent nucleotidyltransferase reaction. Incorporation of an NRTI such as AZT or binding of a non-nucleoside such as nevirapine inhibits DNA polymerization by RT. formed the nevirapine-ternary complex only, despite the fact that this crystal form allows RT-DNA to bind either AZTTP or nevirapine individually. In all three structures, the primer 3′ end AZT was designed to occupy the P site and blocked further incorporation of nucleotides. Incoming AZTTP in the AZTTP-ternary structure occupied the N site (Fig. 2a) , and the thymine was paired with the template adenine base.
Impact of nevirapine or AZTTP binding on the RT-DNA complex
Binding of AZTTP shrunk the unit cell volume of RT-DNA crystals by 1.2%, and binding of nevirapine expanded the volume by 0.67%; however, individual cell parameters changed more upon binding of nevirapine ( Table 1 ). The AZTTP-ternary structure represents an RT-polymerase complex having architecture similar to that in all RT-ternary structures, despite differences in RT or DNA sequences, incoming dNTP or analogs, and crystallization conditions or parameters (Supplementary Fig. 1 and Supplementary Table 1 ) in different studies; the base-pairing, metal chelation and other interactions of AZTTP with RT resemble those of the dTTP 3 substrate and AZTppppA (an ATP-mediated excision product of AZT) 5, 22, 23 in respective cocrystal ternary structures. AZTTP binding causes the tip of the fingers to close and wrap around the dNTP analog ( Supplementary Fig. 2a ). Upon AZTTP binding, the conserved β3-β4 region folds in by ~2 Å, and side chains rearrange to form a closed dNTP-binding pocket in the ternary structure, analogous to that observed upon soaking of GS-9148 (ref. 29) . Contrary to what was found in the binary complex structure determined in the presence of a monoclonal antibody 2 , the fingers subdomain in the current binary structure is not wide open ( Supplementary Fig. 2b) ; however, it is highly flexible. Apart from the fingers rearrangement, AZTTP binding has no major discernible impact on RT-DNA conformation. The 3′-azido group of the primer terminal AZT occupies the position of cofactor metal ion A (Fig. 1) .
The mode of binding and interactions of nevirapine in nevirapineternary and nevirapine-binary 1, 20 structures are similar; however, the binding of nevirapine had a profound effect on RT-DNA conformation compared to the binding of AZTTP. The opening of the nonnucleoside-binding pocket upon nevirapine binding is accompanied by switching of the Tyr181 and Tyr188 rotamer conformations and shearing of the β12-β13-β14 sheet away from the β6-β10-β9 sheet (Fig. 2a-c and Supplementary Movie 1); the β6-β10-β9 sheet contains the polymerase 'catalytic triad' (Asp110, Asp185 and Asp186), and the β12-β13-β14 sheet contains the 'primer grip' that positions the primer strand appropriately for nucleotide incorporation. Upon binding of nevirapine, the primer grip is shifted by ~4 Å, the shifted primer grip lifts the DNA primer terminus away from the P site (Fig. 2a) , and crucial interactions of the conserved catalytic YMMD motif with the primer terminus are lost. The nucleotide complementary to AZT and the upstream template overhang are The template strands are shown as space-filled models. Binding of nevirapine (green space filling) shifts the primer grip by ~4 Å, which pulls the AZT at the primer end away from the P site and repositions the template strand.
(b,c) Electron density maps calculated using six-fold symmetry averaged phases (see Online Methods) show the binding of nevirapine and AZTTP in respective ternary structures; comparison of the two structures show rotamer switching for Tyr181 and Tyr188, shearing of the β12-β13-β14 sheet and the shift of the DNA primer. (d) Repositioning of fingers subdomain based on the superposition and color code described in panel a. In the nevirapine-ternary structure, the template (yellow) overhang is disordered because portions of the repositioned fingers subdomain in the structure would interfere with the template-binding track in the AZTTP-ternary structure (gray).
(e-g) Electrostatic potential surfaces of RT-DNA (e), AZTTP-ternary (f) and nevirapineternary (g) complexes show the conformational variations of the dNTP-binding region upon binding of AZTTP or nevirapine. AZTTP is present only in the AZTTP-ternary (f) structure and is placed in the RT-DNA (e) and nevirapine-ternary (g) structures based on the superposition of palm subdomains. npg a r t i c l e s displaced and are partially or completely disordered in the nevirapineternary structure. The loss of contacts between the template strand and fingers has a profound impact on the positional stability of both, and hence, the fingers subdomain is also weakly ordered. The binding and incorporation of a dNTP requires interactions with the fingers, particularly β3-β4 motif interactions, base pairing with the first template overhang and chelation with the metal ion B 3 . The β3-β4 motif is deformed in the nevirapine-ternary structure, and parts of the fingers are shifted by 5-7 Å into regions that otherwise accommodate the template overhang in catalytically competent RT-DNA structures (Fig. 2d) . The open dNTP-binding site (Fig. 2e) in RT-DNA is closed when AZTTP is bound (Fig. 2f) . The open and rearranged dNTPbinding site (Fig. 2g) in the nevirapine-ternary complex could provide easy access for dNTPs to reach the site; however, this structure did not provide evidence of formation of a closed dNTP-bound quaternary complex when soaked along with AZTTP. The thumb subdomain in the nevirapine-ternary structure has an extended conformation similar to that in the first nevirapine-binary structure (PDB 3HVT) 1 , and the inward movement of the thumb is restricted by the displaced β12-β13-β14 sheet (Supplementary Fig. 3) . The thumb in the higher resolution nevirapine-binary structure (PDB 1VRT) 20 is further extended (Fig. 3a) and involved in crystal contacts. The catalytic triad in the nevirapine-ternary structure has an intermediate conformation (Fig. 3b) between that in the AZTTP-ternary structure and that in the nevirapine-binary 20 structure, suggesting that the YMDD motif may not adopt a rigid conformation in the presence of a non-nucleoside. The fingers subdomain has a semi-open or open conformation in the nevirapine-ternary or nevirapine-binary structure (Fig. 3c) , respectively. The interactions of DNA with palm and fingers subdomains are substantially reduced with nevirapine present (Fig. 3d) ; however, the remaining DNA-protein interactions are less perturbed, despite all subdomains being rearranged. A YMDD sheet (β6-β10-β9) superposition (Supplementary Fig. 4 ) between nevirapine-ternary and RT-DNA binary structures showed that the RNase H active site has moved ~6.5 Å away upon nevirapine binding, and DNA is rearranged while retaining its interactions with the RNase H domain (Fig. 3d) .
DISCUSSION
Primer repositioning obstructs polymerization and excision DNA polymerization by RT is carried out by cyclic repetitions of three structurally distinct steps (Fig. 4a) : (i) binding of dNTP, (ii) nucleotide incorporation with concomitant release of pyrophosphate and (iii) translocation of the incorporated nucleotide from the N site to the P site. Incorporation of an NRTI stalls the cycle and blocks further elongation. An incorporated AZT can readily shuttle between P and N sites, and a pyrophosphate donor such as ATP, with the assistance of AZT-resistance mutations in RT, excises the AZT molecule from the N site. Excision is carried out by completing one reverse cycle of polymerization, structurally represented by RT-DNA-AZT (P-complex) → RT-DNA-AZT (N-complex) 5 → RT-DNA-AZTppppA (excision product complex) 5 . The P′-complex, represented by the nevirapine-ternary structure, is unlikely to accommodate ordered binding of dNTP in a catalytically competent mode. Even if a dNTP were to bind, the primer 3′ end at the P′ site would not allow nucleotide incorporation. 20 (blue) structures shows that the thumb subdomain is hyperextended upon nevirapine binding; the tip of the thumb is ~7.5 and 11 Å away in nevirapine-ternary and nevirapine-binary 20 structures, respectively, from the tip in the AZTTP-ternary structure, based on the described palm superposition. The thumbs of the nevirapine-ternary and the first nevirapine-binary structures 1 , however, are in close proximity, based on the palm superposition ( Supplementary Fig. 3 ). In the higher resolution nevirapine-binary structure 20 A later pre-steady-state kinetics study 19 using elemental effects 31 (dTTPαS versus dTTP) revealed that a conformational state and not the chemical step leading to nucleotide incorporation is blocked by a non-nucleoside inhibitor, and this study favored the primer-grip distortion model 21 as a possible molecular mechanism for non-nucleoside inhibition. The nevirapineternary structure presented in this study defines the impact of nevirapine binding on DNA positioning and RT-DNA interactions. Also, the structure shows that the primer grip repositioning locked the thumb at a hyperextended position 1 and results in a loss of interactions between DNA and the polymerase domain of RT 17 . Although the RT-DNA complex in crystal could bind nevirapine or AZTTP, the complex did not bind both simultaneously and so did not provide direct evidence of dNTP binding. In the nevirapine-ternary structure, the flexible fingers (Fig. 3c) , repositioned template-primer and disordered template overhang would reduce ordered dNTP binding at the N site. However, the flexibility of the fingers may allow alternative modes of dNTP binding to RT in presence of nevirapine. Structures of DNA polymerases (such as the Klenow fragment) 32, 33 have shown that the transition from open to closed fingers is responsible for the binding and incorporation of the correct nucleotides complementing the template overhang, and a recent single-molecule FRET experiment on the Klenow fragment demonstrated that there is a high degree of flexibility of the fingers in the absence of substrates 34 . According to pre-steady state kinetics 19 , dNTPs are expected to bind the nevirapine-ternary complex in a metal-dependent mode but not in a catalytically relevant mode. Structures of DNA polymerases before and after misincorporation of a dATP opposite to an abasic nucleotide have revealed rearrangements of DNA and protein at the polymerase active sites. An open complex of KlenTaq DNA polymerase is formed upon binding of ddATP in a catalytically relevant mode opposite to a template furan 35 ; Tyr671 on the O-helix interacts with the ddATP base and partly compensates for the loss of canonical basepairing. A bacteriophage RB69 DNA polymerase open complex structure 36 (PDB 2P5G) was determined with a dAMP incorporated into the primer opposite to a template furan; apparently, lack of stable interactions (base pairing and stacking) of the terminal dAMP led to multiple conformations of the DNA in the four copies of the complex in the asymmetric unit. HIV-1 RT appears to follow the ' A-rule' for misaligned primer extension opposite to an abasic moiety in vitro 37 , which suggests that the polymerase active site conformation of RT could rearrange to accommodate and incorporate a dNTP without canonical base-pairing at the N site. In contrast to the rearrangements of the DNA polymerases discussed here, a nevirapine-ternary structure of RT is expected to bind dNTP in a polymerase-incompetent mode. Although DNA polymerases share markedly similar domain architecture and chemistry of nucleotide incorporation, characteristics such as rate of nucleotide incorporation, mode and extent of protein-nucleic acid interactions, presence or absence of a proofreading mechanism, fidelity, and rate-limiting steps that select correct versus incorrect nucleotide incorporation 38 are highly enzyme specific.
It is likely that dNTPs enter the N site of the nevirapine-ternary complex (Fig. 2g) and bind in multiple orientations. Alternatively, the primer 3′ end of a nucleic acid duplex may slide past the polymerase active site 17 , and a rearranged dNTP-binding region with the duplex resting over it may define a ordered yet non-productive binding of dNTP. Further biochemical, mutational and structural studies are needed to clarify if there is ordered dNTP-binding to RT and to map the RT-dNTP interactions in the presence of non-nucleosides and nucleic acid.
Conformational states of RT in presence of NNRTI and DNA
Taking the biochemical data, clinical observations and structural states of RT into consideration, it appears that RT with non-nucleosides and nucleic acids in solution would exist in three states: nevirapineternary (state I), nevirapine-binary or switched mode-2 complex 16 (state II) and RT-DNA (state III). Among the three, state III is active and states I and II are inactive for nucleotide incorporation. The relative proportion of the three states would depend upon the binding characteristics and effective concentrations of nevirapine and nucleic acid 16 . The fraction of RT in state III would incorporate nucleotides, unless DNA primers are terminated by NRTIs, which may be a reason why (i) a combination of non-nucleoside and NRTI is more effective in decreasing the viral load in treatment-naive people than when they are treated with individual components and (ii) both NRTI and non-nucleoside resistance mutations co-emerge in Figure 4 A molecular mechanism of nonnucleoside inhibition and impact of DNA binding on resistance to non-nucleoside drugs. (a) Scheme representing effect of non-nucleoside inhibitor binding on DNA polymerization by RT. For incorporating a nucleotide, RT completes three structurally distinct steps in a clockwise cycle. Incorporation of an NRTI drug blocks the cyclic process, leading to a P-complex structure lacking 3′-OH, such as the structure of the RT-DNA-AZTterminated complex. RT removes AZT by following the three steps in a reverse cycle and using a pyrophosphate donor (ATP or PPi).
Binding of a non-nucleoside inhibitor shifts the primer end from the P site to the P′ site. This P′-complex is catalytically incompetent, because the 3′ end is positioned away from the polymerase active site. Release of the non-nucleoside inhibitor would shift the P′-complex to the P-complex and restore DNA polymerization by RT. (b) Positions of three structural elements: the β6-β10-β9 sheet (yellow), β12-β13-β14 sheet (gray) and loop 95-103 (cyan) + Glu138 loop (blue) of p51 in the nevirapineternary structure. These elements are responsible for, and rearranged upon, the binding of nevirapine (green). Non-nucleoside inhibitor binding locks the primer grip away from the active site, whereas binding of dsDNA requires the primer grip to be positioned near the active site, as in the RT-DNA and AZTTP-ternary structures. Red arrows indicate the structural movements (Supplementary Movie 1) between the polymerase-competent and non-nucleoside-bound states.
npg 39 of a triple combination of two NRTIs (tenofovir-disoproxil-fumarate and emtricitabine) and a non-nucleoside (rilpivirine) reported that M184V (or M184I) and E138K mutations are predominantly associated with treatment failure. An arm of the trial that used efavirenz instead of rilpivirine showed M184V (or M184I) and K103N as the predominant resistance mutations, however at a lower frequency. Also, additive effects of nevirapine and AZT have been observed biochemically 24 and clinically 40 .
NNRTI inhibition and resistance mutations
Excision of AZT is diminished in the presence of a non-nucleoside 41, 42 . AZT at the primer 3′ terminus is locked at the P′ position (Fig. 4a) in nevirapine-bound RT and not permitted to translocate back to the N site for excision. Additionally, the distorted dNTP-binding site (Fig. 2g) may decrease the binding of the excision substrate ATP (or PPi). Nevirapine blocks both DNA polymerization and NRTI excision. Binding of nevirapine is accompanied by repositioning of the primer grip away from the active site, whereas binding of DNA in a catalytically competent mode requires the primer grip to be near the active site ( Fig. 4b and Supplementary Movie 1) . A bound nonnucleoside is surrounded by three walls: (i) the β6-β10-β9 sheet, (ii) the β12-β13-β14 sheet and (iii) the 100-105 loop of the p66+Glu138 loop of p51. Rearrangements of the loops would permit entry and exit of most non-nucleosides. In contrast to the pocket residues that directly interact with an inhibitor, the loop residues Lys103 and Glu138 (of p51) do not have extensive interactions with a bound non-nucleoside. The loop mutations facilitate exit of non-nucleosides from the pocket, permitting the primer grip to position nucleic acid in a catalytically relevant mode and shifting the equilibrium toward state III. The mutation K103N confers relatively uniform resistance to chemically diverse non-nucleosides, and as discussed above, two loop mutations E138K and K103N are predominantly associated with treatment failure of the rilpivirine and efavirenz arms, respectively.
Non-nucleoside resistance mutations affect NRTI susceptibility, implying communication between the two sites even in the absence of a non-nucleoside. The common non-nucleoside resistance mutation Y181C enhances AZT sensitivity in a thymidine analog mutant background 43 . A recent study has shown that the E138K mutation is compensatory for M184I(or V) and vice versa 44 . The individual mutations E138K, M184V or M184I reduce the virus fitness by two to three times; however E138K and M184I(or V) in combination restores the viral fitness equivalent to that of wild-type HIV-1.
Conclusions
The current structures of three RT complexes, the earlier RT structures and the abundant available clinical and biochemical data enabled us to analyze the specific effects of non-nucleosides on RT structure and function. Nevirapine binding has a direct impact on the RT-DNA complex. The primer grip is displaced, and consequently, the primer terminus moves out, the thumb is locked at a hyperextended position 1 , interactions between DNA and the polymerase domain are decreased 17 , the dNTP-binding site is distorted and the RNase H active site is repositioned with respect to the polymerase active site. Enhanced understanding of the mechanistic details of nonnucleoside inhibition may also aid development of allosteric inhibitors that would block the conformational mobility of molecular machines such as hepatitis C NS5B polymerase 45 , bacterial RNA polymerase 46 and other macromolecular assemblies associated with various diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Accession codes. The atomic coordinates and structure factors for the structures of the RT-dsDNA, AZTTP-ternary and nevirapineternary complexes have been deposited in the Protein Data Bank under accession codes 3V6D, 3V4I and 3V81 respectively. 
ONLINE METHODS
RT expression, RT-DNA cross-linking and purification. RT construct RT127A used for the current structural studies was derived from a previously reported construct RT13A 47 . The mutation D498N in the RT127A construct was introduced using the methods described therein. Asp498 is a part of the RNase H active site. The D498N mutant RT blocks RNase H activity; however, the mutant RT has polymerase activity comparable to wild-type RT 48 . The D498N mutant RT was expressed and purified as previously reported 47 . Briefly, the RT was expressed in BL21-CodonPlus-RIL cells, induced with 1 mM IPTG at an A 600 of 0.9, followed by expression at 37 °C for 3 h. The cells were sonicated at a power output of ~45 W with a Misonix 3000 sonicator. The samples were purified using a nickel-nitrilotriacetic acid (Ni-NTA) column according to the manufacturer's recommendations (Qiagen). The final purification step was carried out using a Mono Q column, and the purified RT samples were buffer exchanged into 10 mM Tris, pH 8.0, and 75 mM NaCl.
The 27-mer DNA template (5′-ATGGAAGGCGCCCGAACAGGGACTG TG-3′) was synthesized by Integrated DNA Technologies. The 20-mer primer (5′-ACAGTCCCTGTTCGGGCGCC-3′) bearing a cross-linkable thioalkyl tether (on G in the primer strand) 49 was custom synthesized by Midland Certified Reagent Company, using phosphoramidite that was custom synthesized by Chemgenes, and the primer was annealed to the template. The 27:20-mer dsDNA was cross-linked to RT127A at the mutated Q258C site of p66, and the crosslinked primer was extended with an AZT at the 3′ end through RT polymerization 50 . The cross-linked RT127A-DNA (AZT-terminated primer) complex was purified using Ni-NTA and heparin columns in tandem as previously described 50 . The His tag was removed by adding human rhinovirus 14 3C protease at a 1:10 ratio to the RT-DNA complex at 4 °C for 48 h. Ni-NTA beads were added to remove the cleaved His tag and His-tagged protease. An Amicon Ultra-4 Ultracel unit (30-kDa cutoff) was used to exchange the buffer into 75 mM NaCl, 10 mM Tris-HCl, pH 8.0. The protein was concentrated to 15 mg ml −1 .
Crystallization. Sitting drops of 0.5 µl of protein plus 0.5 µl of well solution were set up at 4 °C on Combiclover Jr. plates from Emerald BioStructures. The well solution contained 10-12% PEG 8000 (w/v), 50 mM Bis-Tris propane, pH 6.8-7.2, 100 mM (NH 4 ) 2 SO 4 , 5% sucrose (w/v), 5% glycerol (v/v) and 20 mM MgCl 2 . Crystals appeared in a few days and continued growing slowly for an additional 2-3 weeks to a full size of ~200 µm long and 50-150 µm thick. For the nevirapine soak below, the crystals were grown with 2 mM AZTTP added to the drop. AZTTP plus nevirapine or nevirapine soaks. In an effort to obtain a structure of the RT-DNA in complex with both AZTTP at the dNTP-binding site and nevirapine at the non-nucleoside inhibitor-binding site, the RT-DNA (AZT-terminated primer) ternary complex crystals, grown in 2 mM AZTTP, were transferred to 150 µl of the stabilization solution (same as for the binary complex dataset above) for 10-15 min to remove free AZTTP and Mg 2+ ions.
The crystals were then transferred to 50 µl of the stabilization solution plus 2 mM nevirapine for 1 h, then 50 µl with 2 mM each of nevirapine and AZTTP and 20 mM MgCl 2 for 15 min. Finally the crystals were stabilized for one minute in 50 µl of this solution, raised to 20% glycerol (v/v) for cryoprotection. This experiment produced only the nevirapine-ternary complex; no Mg 2+ ion or AZTTP binding was detected at the dNTP-binding site when nevirapine was bound to HIV-1 RT in datasets from multiple crystals or when Mn 2+ was substituted for Mg 2+ . Crystals soaked with nevirapine after washing out Mg 2+ ions and without adding AZTTP also produced the nevirapine-ternary complex.
X-ray crystallography. Multiple X-ray diffraction datasets were collected from the above-described crystals and duplicate soaks using synchrotron sources: the F1 beamline at CHESS and the X25 beamline at BNL. The data were processed and scaled using HKL2000 (ref. 51) ( Table 1 ). The diffraction data from the nevirapine-ternary complex crystals were highly anisotropic, and observed structure factors were corrected using the University of California, Los Angeles MBI -Diffraction Anisotropy Server 52 . The structures were solved by molecular replacement, using protein atoms in the crystal structure of RT-DNAtenofovir-diphosphate 28 , and the subdomains were positioned by rigid-body refinements in which each RT molecule was divided into thirteen segments. Each crystal structure had two RT complexes per asymmetric unit. The three datasets corresponding to the three RT complexes were non-isomorphous with each other, which allowed us to conduct six-fold real-space averaging among the three crystal forms and two-fold noncrystallographic symmetry within each crystal form. DMMULTI 53 , as implemented in CCP4, was used for averaging and phase extension. The electron density maps calculated from averaged phases and figures of merit helped position the individual amino acid residues, the DNA, the nevirapine and the AZTTP. The fingers subdomain is the least ordered region in all three structures. The degree of disorder of the fingers varies from higher to lower in the sequence nevirapine-ternary > RT-DNAbinary > AZTTP-ternary; the binding of AZTTP increased the positional stability of the fingers subdomain in the AZTTP-ternary structure. Individual structures were refined using PHENIX 54 , and the model building was carried out using COOT 55 . The figures showing structural information were generated using PyMOL (http://www.pymol.org/).
